Ceres Nanosciences Establishes Nine Wastewater-based COVID-19 ... - 10 November 2021 00:33

MANASSAS, Va., Nov. 10, 2021 /PRNewswire-AsiaNet/ -- Ceres Nanosciences (Ceres), a privately held company that makes innovative products to improve life science research and diagnostic testing, is announcing the establishment of nine wastewater-based epidemiology centers of excellence, as part of th...

  INOVIO Receives U.S. FDA Authorization to Proceed with INNOVAT... - 10 November 2021 00:00

PLYMOUTH MEETING, Pa., Nov. 9, 2021 /PRNewswire-AsiaNet/ -- - FDA Lifts Partial Clinical Hold on INNOVATE Phase 3 Segment INOVIO (NASDAQ: INO), a biotechnology company focused on bringing to market precisely designed DNA medicines to help protect people from infectious diseases and treat cancer and HPV...

  RedHill Biopharma and South Korea's Kukbo Co. Announce a Strat... - 08 November 2021 22:48

TEL AVIV, Israel and RALEIGH, NC, Nov. 8, 2021 /PRNewswire-AsiaNet/ -- RedHill received the first tranche of $5 million in a private placement of restricted stock priced at $6.04 per ADS, representing a 20% premium based on the 30 trading days' volume weighted average price (VWAP) ending on the effective date Red...

  Vazyme to Reveal Its Latest COVID-19 Testing Products and Solu... - 08 November 2021 20:56

DUSSELDORF, Germany, Nov. 8, 2021 /PRNewswire-AsiaNet/ -- Chinese biotechnology company Nanjing Vazyme Biotech Co., Ltd (Vazyme) will exhibit its advanced COVID-19 testing products and solutions in Hall 3 Stand F 94 at MEDICA 2021, the world's leading trade fair for the medical sector, in Messe Düsseldor...

  Bugworks Research Announces the First in Human Phase 1 Study o... - 08 November 2021 10:00

BANGALORE, India, SARATOGA, Calif. and ADELAIDE, Nov. 8, 2021 /PRNewswire-Asianet/ -- Bugworks research today announced that the first human dose was administered in a Phase 1 clinical trial evaluating BWC0977: a next generation broad-spectrum, novel bacterial topoisomerase inhibitor (NBTI), supported by Combating Antibiotic-Re...

  Wegovy(TM) demonstrated significant and sustained weight loss ... - 06 November 2021 01:16

BAGSVÆRD, Denmark, Nov. 5, 2021 /PRNewswire-AsiaNet/ -- - The STEP 5 trial demonstrated an average weight loss of 15.2% with Wegovy(TM) at 104-weeks when used with a reduced calorie meal plan and increased physical activity vs. 2.6% with placebo - The trial also showed that 77.1% of study participant...

  2020 Tang Prize Awarding Ceremony and Laureate Lecture Go Virt... - 05 November 2021 13:00

TAIPEI,Nov.5,2021/PRNewswire-AsiaNet/-- The 2020 Tang Prize Awarding Ceremony is scheduled to be held online at 2p.m. Taipei time(GMT+8) on Saturday, Nov.20,2021. The Tang Prize Foundation will livestream the whole event, which features eight laureates receiving the awards and making th...

  Associates of Cape Cod Inc. Announces the Release of its One M... - 05 November 2021 00:30

E. FALMOUTH, Mass., Nov. 5, 2021 /PRNewswire-AsiaNet/ -- ACC proudly announces that it has achieved the release of its millionth juvenile horseshoe crab to the wild, as a result of its species sustainability project. The program is the first of its kind to release ecologically significant numbers of Nor...

  Taizhou, China: Building a Famous Chinese Medical City with Ef... - 04 November 2021 23:39

TAIZHOU, China, Nov. 4, 2021 /Xinhua-AsiaNet/-- Recently, the 12th China (Taizhou) International Medical Expo was held in China Medical City in Taizhou, China. Starting from the needs of normalized prevention and control of the epidemic, this year's expo made an "online+on-site" integrated exhi...

  Menarini Receives FDA Orphan Drug Designation for SEL24/MEN170... - 04 November 2021 22:18

FLORENCE, Italy, Nov. 4, 2021 /PRNewswire-AsiaNet/ -- The Menarini Group announced today that the U.S. Food and Drug Administration (FDA) granted orphan drug designation (ODD) to SEL24/MEN1703 for the treatment of Acute Myeloid Leukemia (AML). SEL24/MEN1703 is a first-in-class, orally available, dual...